CSc1nc(N)c2ncn([C@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@@H]3O)c2n1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?